ANN ARBOR, Mich.–(BUSINESS WIRE)–OcuSciences, a medical device company developing advanced ocular imaging technologies to help clinicians better understand retinal dystrophies and other leading causes of blindness, today announced that it has receive…
Author: Business Wire
Broadwood Partners Comments on STAAR Surgical’s Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the recent Current Report on Form 8-K filed by STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) with the U.S. Securities and…
EyeCare Partners to Present Leading Research and Expertise at the American Academy of Ophthalmology (AAO) 2025 in Orlando
ST. LOUIS–(BUSINESS WIRE)– #elevatingeyecare–EyeCare Partners announced its participation in the American Academy of Ophthalmology (AAO) 2025, Friday, Oct. 17, through Monday, Oct. 20.
Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced today that …
Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences
LONDON & SEATTLE–(BUSINESS WIRE)– #InvestorConference–Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood,…
Tilak Healthcare Obtains Reimbursement for Odysight®, the First Remote Monitoring Solution in Ophthalmology, via the PECAN Progam
PARIS–(BUSINESS WIRE)–Tilak Healthcare, a pioneering company and leader in digital health for chronic eye disease monitoring, announces that it has received a positive opinion from the French National Health Authority (HAS) for the exceptional reimbu…
New Citruslabs Study Finds Droptics Eye Drops Help Refresh, Hydrate, and Energize Screen-Weary Eyes
LOS ANGELES–(BUSINESS WIRE)–A new study from Citrulabs, a leading clinical research organization, found that Droptics, the first-of-its-kind eye drop designed specifically for the digital generation, delivers measurable relief for individuals experie…
The Institute of Clinical Research Launches New Company Membership Scheme to Support Clinical Research Professionals
LONDON–(BUSINESS WIRE)– #CRO–The Institute of Clinical Research (The ICR) is delighted to announce the launch of its Company Membership Scheme, an initiative designed to strengthen professional development and collaboration across the clinical resea…
STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today provided the following statement in resp…
Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote “AGAINST” Sale to Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today announced that Glass, Lewis & Co., LLC (“Glass Lewis”), a leading independent proxy advisory firm, has recommended that the shareholders of STAAR Sur…
Howe Innovation Center at Perkins Hosts DisabilityTech Pitch Challenge With Mitsubishi Electric
WATERTOWN, Mass.–(BUSINESS WIRE)–On October 7, the Howe Innovation Center at Perkins School for the Blind hosted a DisabilityTech Pitch Challenge featuring nine start-up companies showcasing their assistive and adaptive technologies to create a more …
Horizon Surgical Systems Completes World’s First Robotic-Assisted Cataract Surgery
LOS ANGELES–(BUSINESS WIRE)–Horizon Surgical Systems (Horizon), a robotics company revolutionizing ophthalmic surgery through the application of robotics and artificial intelligence (AI), today announced the world’s first cataract surgery performed u…
Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release third…
GenSight Biologics Reports Cash Position as of September 30, 2025
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (“GenSight Biologics” or the “Company”) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for ret…
Sightview to Unveil New Design, User Experience at AAO 2025
DURHAM, N.C.–(BUSINESS WIRE)– #EHR–Sightview’s new UI brings workflow and efficiency enhancements, developed and tested with optometrists, ophthalmologists and opticians.
National Vision Launches 2025-2026 Scholarship Program, Spotlighting Technology’s Role in Access to Eye Care
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE), one of the largest optical retail companies in the United States, announced today that its annual scholarship program is open for entries, offering eligible optometry students …
EyeDura Initiates Preclinical Efficacy Studies to Advance Insulin-Based Treatment for Neurotrophic Keratitis
NEW YORK–(BUSINESS WIRE)–EyeDura Initiates Preclinical Efficacy Studies to Advance Insulin-Based Treatment for Neurotrophic Keratitis
Yunqi Capital, One of STAAR Surgical Company’s Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon
HONG KONG–(BUSINESS WIRE)–Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:STAA), today rel…
Fuchs Endothelial Corneal Dystrophy Market Report 2025-2035: Epidemiology, Regulatory Landscape, Ongoing Clinical Trials, Market Dynamics, Patent Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Fuchs Endothelial Corneal Dystrophy Market – A Global and Regional Analysis: Focus on Treatment Method, End User, and Region – Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. T…